Crossmark Global Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

Crossmark Global Holdings’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,169	Closed	-$237K	–	1622
2018 Q1	$237K	Sell	12,169 -3,579	-23%	-$70.2K	0.01%	1419
2017 Q4	$262K	Sell	15,748 -1,301	-8%	-$23.8K	0.01%	1451
2017 Q3	$346K	Buy	+17,049	New	+$326K	0.01%	1216
2016 Q3	$346K	Buy	+17,049	New	+$458K	0.01%	1216

Crossmark Global Holdings's IPXL Position: Q2 2018 in Review

Crossmark Global Holdings sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 12,169 shares — an estimated $237K sold.

Crossmark Global Holdings first reported a position in IPXL in Q3 2016 and held it in 4 quarters. The position peaked at $346K in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Crossmark Global Holdings reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Crossmark Global Holdings sold 12,169 Impax Laboratories, Inc. shares in Q2 2018, an estimated $237K.
Crossmark Global Holdings first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 4 quarters.
Crossmark Global Holdings's Impax Laboratories, Inc. position peaked at $346K in Q3 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Crossmark Global Holdings's 13F filing for Q2 2018, filed 31 Jul 2018.